Phibro Animal Health (PAHC) Stock Forecast & Price Target

$23.74 -0.02 (-0.08%)

(As of 11/22/2024 ET)

Phibro Animal Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Sell

Based on 4 Analyst Ratings

Sell
3

Hold
1

Buy
0

Based on 4 Wall Street analysts who have issued ratings for Phibro Animal Health in the last 12 months, the stock has a consensus rating of "Strong Sell." Out of the 4 analysts, 3 have given a sell rating, and 1 has given a hold rating for PAHC.

Consensus Price Target

$16.50
-30.50% Downside

According to the 4 analysts' twelve-month price targets for Phibro Animal Health, the average price target is $16.50. The highest price target for PAHC is $22.00, while the lowest price target for PAHC is $9.00. The average price target represents a forecasted downside of -30.50% from the current price of $23.74.

Get the Latest News and Ratings for PAHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Phibro Animal Health and its competitors.

PAHC Analyst Ratings Over Time

Type	Current Forecast 11/24/23 to 11/23/24	1 Month Ago 10/25/23 to 10/24/24	3 Months Ago 8/26/23 to 8/25/24	1 Year Ago 11/24/22 to 11/24/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)
Hold	1 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	3 Sell rating(s)	3 Sell rating(s)	2 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$16.50	$15.00	$14.75	$18.33
Forecasted Upside	-30.50% Downside	-35.92% Downside	-29.56% Downside	73.94% Upside
Consensus Rating	Strong Sell	Strong Sell	Reduce	Moderate Buy

“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

PAHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PAHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Phibro Animal Health Stock vs. The Competition

Type	Phibro Animal Health	Medical Companies	S&P 500
Consensus Rating Score	1.25	2.80	2.50
Consensus Rating	Strong Sell	Moderate Buy	Moderate Buy
Predicted Upside	-30.50% Downside	27,098.21% Upside	7.66% Upside
News Sentiment Rating	Neutral News See Recent PAHC News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/12/2024	Barclays 3 of 5 stars		Boost Target	Underweight ➝ Underweight	$13.00 ➝ $20.00	-21.87%
9/10/2024	JPMorgan Chase & Co. 3 of 5 stars		Initiated Coverage	Neutral	$22.00	+7.16%
8/30/2024	Bank of America 4 of 5 stars		Boost Target	Underperform ➝ Underperform	$13.00 ➝ $15.00	-30.14%
12/7/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Underperform	$9.00	-21.33%
11/9/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$17.00 ➝ $16.00	+50.66%
8/29/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$21.00	+40.19%
12/21/2022	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Wright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$18.00	+41.18%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 08:43 PM ET.

PAHC Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Phibro Animal Health is $16.50, with a high forecast of $22.00 and a low forecast of $9.00.
: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 3 sell ratings and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "strong sell" PAHC shares.
: According to analysts, Phibro Animal Health's stock has a predicted downside of -30.50% based on their 12-month stock forecasts.
: Phibro Animal Health has been rated by research analysts at Bank of America, Barclays, and JPMorgan Chase & Co. in the past 90 days.
: Analysts like Phibro Animal Health less than other "medical" companies. The consensus rating for Phibro Animal Health is Strong Sell while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PAHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Check out the $100 Challenge now

This page (NASDAQ:PAHC) was last updated on 11/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Phibro Animal Health (PAHC) Stock Forecast & Price Target